TERAWULF INC. - Quarter Report: 2011 June (Form 10-Q)
Table of Contents
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
þ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the Quarterly Period Ended June 30, 2011
or
o | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the Transition Period From to .
Commission file number 000-25727
IKONICS CORPORATION
Minnesota | 41-0730027 | |
(State or other jurisdiction of | (I.R.S. employer | |
incorporation or organization) | identification no.) | |
4832 Grand Avenue | ||
Duluth, Minnesota | 55807 | |
(Address of principal executive offices) | (Zip code) |
(218) 628-2217
Issuers telephone number
Not Applicable
Check whether the issuer (1) filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files.) Yes þ No o
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes o No þ
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act.
Large accelerated filer o | Accelerated filer o | Non-accelerated filer o | Smaller reporting company þ | |||
(Do not check if a smaller reporting company) |
State the number of shares outstanding of each of the issuers classes of common
equity, as of the latest practical date: Common Stock, $.10 par value 1,983,587 shares
outstanding as of August 10, 2011.
IKONICS Corporation
QUARTERLY REPORT ON FORM 10-Q
Table of Contents
PART I FINANCIAL INFORMATION
ITEM 1. Condensed Financial Statements
IKONICS CORPORATION
CONDENSED BALANCE SHEETS
June 30 | December 31 | |||||||
2011 | 2010 | |||||||
(unaudited) | ||||||||
ASSETS |
||||||||
CURRENT ASSETS: |
||||||||
Cash |
$ | 1,103,355 | $ | 1,291,383 | ||||
Short-term investments |
2,231,948 | 2,217,990 | ||||||
Trade receivables, less allowance of $54,000 in 2011 and
$60,000 in 2010 |
2,226,709 | 1,883,428 | ||||||
Inventories |
2,577,605 | 2,198,064 | ||||||
Prepaid expenses and other assets |
101,662 | 63,965 | ||||||
Deferred income taxes |
157,000 | 157,000 | ||||||
Total current assets |
8,398,279 | 7,811,830 | ||||||
PROPERTY, PLANT, AND EQUIPMENT, at cost: |
||||||||
Land and building |
5,901,131 | 5,888,445 | ||||||
Machinery and equipment |
2,510,803 | 2,455,238 | ||||||
Office equipment |
688,476 | 642,100 | ||||||
Vehicles |
234,650 | 234,650 | ||||||
9,335,060 | 9,220,433 | |||||||
Less accumulated depreciation |
4,404,526 | 4,207,500 | ||||||
4,930,534 | 5,012,933 | |||||||
INTANGIBLE ASSETS, less accumulated amortization of $401,941 in
2011 and $376,983 in 2010 |
333,936 | 317,168 | ||||||
$ | 13,662,749 | $ | 13,141,931 | |||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
CURRENT LIABILITIES: |
||||||||
Accounts payable |
$ | 462,495 | $ | 441,830 | ||||
Accrued compensation |
359,095 | 282,196 | ||||||
Other accrued expenses |
39,802 | 45,868 | ||||||
Income taxes payable |
17,416 | 8,090 | ||||||
Total current liabilities |
878,808 | 777,984 | ||||||
DEFERRED INCOME TAXES |
171,000 | 171,000 | ||||||
Total liabilities |
1,049,808 | 948,984 | ||||||
STOCKHOLDERS EQUITY: |
||||||||
Preferred stock, par value $.10 per share; authorized 250,000 shares; issued
none |
||||||||
Common stock, par value $.10 per share; authorized 4,750,000 shares;
issued and outstanding 1,983,587 shares in 2011 and 1,973,357 shares
in 2010 |
198,359 | 197,336 | ||||||
Additional paid-in capital |
2,337,017 | 2,263,176 | ||||||
Retained earnings |
10,077,565 | 9,732,435 | ||||||
Total stockholders equity |
12,612,941 | 12,192,947 | ||||||
$ | 13,662,749 | $ | 13,141,931 | |||||
See notes to condensed financial statements
3
Table of Contents
IKONICS CORPORATION
CONDENSED STATEMENTS OF OPERATIONS (Unaudited)
Three Months | Six Months | |||||||||||||||
Ended June 30 | Ended June 30 | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
NET SALES |
$ | 4,587,432 | $ | 4,248,055 | $ | 8,240,531 | $ | 7,932,632 | ||||||||
COST OF GOODS SOLD |
2,733,442 | 2,418,296 | 4,919,698 | 4,619,078 | ||||||||||||
GROSS PROFIT |
1,853,990 | 1,829,759 | 3,320,833 | 3,313,554 | ||||||||||||
SELLING, GENERAL AND
ADMINISTRATIVE EXPENSES |
1,267,695 | 1,122,475 | 2,611,336 | 2,322,864 | ||||||||||||
RESEARCH AND DEVELOPMENT
EXPENSES |
137,488 | 204,498 | 237,399 | 365,202 | ||||||||||||
INCOME FROM OPERATIONS |
448,807 | 502,786 | 472,098 | 625,488 | ||||||||||||
INTEREST INCOME |
4,781 | 3,886 | 9,343 | 7,405 | ||||||||||||
INCOME BEFORE INCOME TAXES |
453,588 | 506,672 | 481,441 | 632,893 | ||||||||||||
INCOME TAX EXPENSE |
144,042 | 163,400 | 134,553 | 141,280 | ||||||||||||
NET INCOME |
$ | 309,546 | $ | 343,272 | $ | 346,888 | $ | 491,613 | ||||||||
EARNINGS PER COMMON SHARE: |
||||||||||||||||
Basic |
$ | 0.16 | $ | 0.17 | $ | 0.18 | $ | 0.25 | ||||||||
Diluted |
$ | 0.16 | $ | 0.17 | $ | 0.17 | $ | 0.25 | ||||||||
WEIGHTED AVERAGE COMMON SHARES
OUTSTANDING : |
||||||||||||||||
Basic |
1,982,869 | 1,972,447 | 1,979,714 | 1,969,767 | ||||||||||||
Diluted |
1,987,662 | 1,974,158 | 1,984,040 | 1,970,587 | ||||||||||||
See notes to condensed financial statements.
4
Table of Contents
IKONICS CORPORATION
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)
Six Months | ||||||||
Ended June 30 | ||||||||
2011 | 2010 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
||||||||
Net income |
$ | 346,888 | $ | 491,613 | ||||
Adjustments to reconcile net income to net cash provided by (used in)
operating activities: |
||||||||
Depreciation |
197,026 | 202,478 | ||||||
Amortization |
24,958 | 27,626 | ||||||
Stock based compensation |
12,642 | 14,487 | ||||||
Gain on sale of equipment and vehicles |
| (10,766 | ) | |||||
Loss on intangible asset abandonment |
| 29,918 | ||||||
Changes in working capital components: |
||||||||
Trade receivables |
(343,281 | ) | (39,844 | ) | ||||
Inventories |
(379,541 | ) | 49,360 | |||||
Prepaid expenses and other assets |
(37,697 | ) | (161,798 | ) | ||||
Accounts payable |
20,665 | 61,168 | ||||||
Accrued expenses |
70,833 | (22,251 | ) | |||||
Income taxes payable |
3,659 | 20,131 | ||||||
Net cash provided by (used in) operating activities |
(83,848 | ) | 662,122 | |||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
||||||||
Purchases of property, plant and equipment |
(114,627 | ) | (121,646 | ) | ||||
Proceeds from sale of equipment and vehicles |
| 19,200 | ||||||
Purchases of intangibles |
(41,726 | ) | (22,660 | ) | ||||
Purchases of short-term investments |
(1,828,148 | ) | (1,207,412 | ) | ||||
Proceeds on sale of short-term investments |
1,814,190 | 400,000 | ||||||
Net cash used in investing activities |
(170,311 | ) | (932,518 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
||||||||
Repurchase of common stock |
(2,079 | ) | | |||||
Proceeds from exercise of stock options |
68,210 | 33,990 | ||||||
Net cash provided by financing activities |
66,131 | 33,990 | ||||||
NET DECREASE IN CASH |
(188,028 | ) | (236,406 | ) | ||||
CASH AT BEGINNING OF PERIOD |
1,291,383 | 1,304,586 | ||||||
CASH AT END OF PERIOD |
$ | 1,103,355 | $ | 1,068,180 | ||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION |
||||||||
Cash paid for income taxes, net of refunds received of $4,090 and
$81,422, respectively |
$ | 130,894 | $ | 156,149 | ||||
See notes to condensed financial statements.
5
Table of Contents
IKONICS CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
(Unaudited)
1. | Basis of Presentation |
The balance sheet of IKONICS Corporation (the Company) as of June 30, 2011, and the related statements of operations for the three and six months ended June 30, 2011 and 2010, and cash flows for the six months ended June 30, 2011 and 2010, have been prepared without being audited. |
In the opinion of management, these statements reflect all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the financial position of IKONICS Corporation as of June 30, 2011, and the results of operations and cash flows for all periods presented. |
Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America, have been condensed or omitted. Therefore, these statements should be read in conjunction with the financial statements and notes thereto included in the Companys Annual Report on Form 10-K for the year ended December 31, 2010. |
The results of operations for interim periods are not necessarily indicative of results that will be realized for the full fiscal year. |
2. | Short-Term Investments |
The Companys $2,232,000 of short-term investments is comprised of fully insured certificates of deposit with maturities ranging from six to twelve months and interest rates ranging from 0.4% to 1.6%. |
3. | Inventories |
The major components of inventories are as follows: |
June 30, 2011 | Dec 31, 2010 | |||||||
Raw materials |
$ | 1,793,037 | $ | 1,403,875 | ||||
Work-in-progress |
314,514 | 294,006 | ||||||
Finished goods |
1,536,976 | 1,493,226 | ||||||
Reduction to LIFO cost |
(1,066,922 | ) | (993,043 | ) | ||||
Total Inventory |
$ | 2,577,605 | $ | 2,198,064 | ||||
6
Table of Contents
IKONICS CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
(Unaudited)
4. | Earnings Per Common Share (EPS) |
Basic EPS is calculated using net income divided by the weighted average of common shares outstanding. Diluted EPS is similar to Basic EPS except that the weighted average number of common shares outstanding is increased to include the number of additional common shares that would have been outstanding if the potential dilutive common shares, such as those shares subject to options, had been issued. |
Shares used in the calculation of diluted EPS are summarized below: |
Three Months Ended | ||||||||
June 30, 2011 | June 30, 2010 | |||||||
Weighted average common shares outstanding |
1,982,869 | 1,972,447 | ||||||
Dilutive effect of stock options |
4,793 | 1,711 | ||||||
Weighted average common and common equivalent shares outstanding |
1,987,662 | 1,974,158 | ||||||
Six Months Ended | ||||||||
June 30, 2011 | June 30, 2010 | |||||||
Weighted average common shares outstanding |
1,979,714 | 1,969,767 | ||||||
Dilutive effect of stock options |
4,326 | 820 | ||||||
Weighted average common and common equivalent shares outstanding |
1,984,040 | 1,970,587 | ||||||
Options to purchase 5,000 shares of common stock with a weighted average price of $8.08 were outstanding during the six months ended June 30, 2011, but were excluded from the computation of common share equivalents because they were anti-dilutive. There were no anti-dilutive options outstanding during the quarter ended June 30, 2011. For the three and six months ended June 30, 2010, options to purchase 16,250 shares of common stock with a weighted average price of $7.89 were outstanding, but were excluded from the computation of common share equivalents because they were anti-dilutive. |
5. | Stock-based Compensation |
The Company maintains a stock incentive plan which authorizes the issuance of up to 442,750 shares of common stock. Of those shares, 31,250 were subject to outstanding options and 124,323 were reserved for future grants at June 30, 2011. The plan provides for granting eligible participants stock options or other stock awards, as described by the plan, at option prices ranging from 85% to 110% of fair market value at the date of grant. Options granted expire up to seven years after the date of grant. Such options generally become exercisable over a one to three year period. |
The Company charged compensation cost of $6,500 against income for the three months ended June 30, 2011 compared to $7,600 for the three months ended June 30, 2010. For the first six months of 2011, the Company charged compensation cost of approximately $12,600 against income compared to approximately $14,500 for the same period in 2010. As of June 30, 2011 there was approximately $33,700 of unrecognized compensation cost related to unvested share-based compensation awards granted. That cost is expected to be recognized over the next three years. |
The Company receives a tax deduction for certain stock option exercises during the period in which the options are exercised, generally for the excess of the market price at the time the stock options are exercised over the exercise price of the options, which increased the APIC pool, which is the amount that |
7
Table of Contents
IKONICS CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
(Unaudited)
represents the pool of excess tax benefits available to absorb tax shortages. There were no excess tax benefits recognized during the three or six month periods ended June 30, 2011 and 2010, respectively. The Companys APIC pool totaled approximately $111,000 at June 30, 2011 and December 31, 2010, respectively. |
Proceeds from the exercise of stock options were $68,000 and $34,000 for the six months ended June 30, 2011 and 2010, respectively. |
The fair value of options granted during the six months ended June 30, 2011 and 2010 were estimated using the Black-Scholes option pricing model with the following assumptions: |
2011 | 2010 | |||||||
Dividend yield |
0 | % | 0 | % | ||||
Expected volatility |
41.3 | % | 45.2 | % | ||||
Expected life of option |
Five Years | Five Years | ||||||
Risk-free interest rate |
2.0 | % | 2.5 | % | ||||
Fair value of each option on grant date |
$ | 2.83 | $ | 3.08 |
There were 4,000 options granted during each of the six months ended June 30, 2011 and 2010. |
Stock option activity during the six months ended June 30, 2011 was as follows: |
Weighted | ||||||||
Average | ||||||||
Exercise | ||||||||
Shares | Price | |||||||
Outstanding at beginning of period |
40,500 | $ | 6.38 | |||||
Granted |
4,000 | 7.53 | ||||||
Exercised |
(10,500 | ) | 6.50 | |||||
Expired and forfeited |
(2,750 | ) | 7.90 | |||||
Outstanding at June 30, 2011 |
31,250 | 6.35 | ||||||
Exercisable at June 30, 2011 |
16,332 | 6.40 | ||||||
The aggregate intrinsic value of all options outstanding and for those exercisable at June 30, 2011 was $51,000 and $26,000, respectively. |
8
Table of Contents
IKONICS CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
(Unaudited)
6. | Segment Information |
The Companys reportable segments are strategic business units that offer different products and have varied customer bases. In previous years there were three reportable segments: Domestic, Export, and IKONICS Imaging. Domestic sells screen printing film, emulsions, and inkjet receptive film to distributors located in the United States and Canada. IKONICS Imaging sells photo resistant film, art supplies, glass, metal medium and related abrasive etching equipment to end user customers located in the United States and Canada. The IKONICS Imagining segment also included products and customers for etched composites, ceramics, glass and silicon wafers along with sound deadening technology to the aerospace industry, which beginning in 2011 the Company now defines as Micromachining. In addition, IKONICS Imaging included products and customers related to proprietary inkjet technology used for mold texturing and referred to by the Company as Digital Texturing (DTX). Export sells primarily the same products as Domestic and the IKONICS Imaging products not related to Micromachining or DTX. Beginning in 2011, the Company no longer includes Micromaching and DTX financial information under the IKONICS Imaging segment. The financial information for Micromaching and DTX are combined into a new segment called Other. As the Company is unable to provide comparable 2010 financial information for the newly defined segments, the Company will disclose in 2011 both the new basis and previous basis of segment reporting. The accounting policies applied to determine the segment information are the same as those described in the summary of significant accounting policies included in the Companys Annual Report on Form 10-K for the year ended December 31, 2010. |
Management evaluates the performance of each segment based on the components of divisional income, and does not allocate assets and liabilities to segments except for accounts receivables which is allocated based on the previous segmentation. Financial information with respect to the reportable segments follows: |
For the three months ended June 30, 2011 (previous segment method): |
IKONICS | ||||||||||||||||||||
Domestic | Export | Imaging | Unalloc. | Total | ||||||||||||||||
Net sales |
$ | 1,796,286 | $ | 1,613,353 | $ | 1,177,793 | $ | | $ | 4,587,432 | ||||||||||
Cost of goods sold |
1,015,528 | 1,187,819 | 530,095 | | 2,733,442 | |||||||||||||||
Gross profit |
780,758 | 425,534 | 647,698 | | 1,853,990 | |||||||||||||||
Selling, general and
administrative* |
307,975 | 145,389 | 484,696 | 329,635 | 1,267,695 | |||||||||||||||
Research and
development* |
| | | 137,488 | 137,488 | |||||||||||||||
Income from operations |
$ | 472,783 | $ | 280,145 | $ | 163,002 | $ | (467,123 | ) | $ | 448,807 | |||||||||
For the three months ended June 30, 2010 (previous segment method): |
IKONICS | ||||||||||||||||||||
Domestic | Export | Imaging | Unalloc. | Total | ||||||||||||||||
Net sales |
$ | 1,791,392 | $ | 1,472,989 | $ | 983,674 | $ | | $ | 4,248,055 | ||||||||||
Cost of goods sold |
903,151 | 1,004,707 | 510,438 | | 2,418,296 | |||||||||||||||
Gross profit |
888,241 | 468,282 | 473,236 | | 1,829,759 | |||||||||||||||
Selling, general and
administrative* |
255,752 | 166,995 | 283,406 | 416,322 | 1,122,475 | |||||||||||||||
Research and
development* |
| | | 204,498 | 204,498 | |||||||||||||||
Income from operations |
$ | 632,489 | $ | 301,287 | $ | 189,830 | $ | (620,820 | ) | $ | 502,786 | |||||||||
9
Table of Contents
IKONICS CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
(Unaudited)
For the three months ended June 30, 2011 (new segment method): |
IKONICS | ||||||||||||||||||||||||
Domestic | Export | Imaging | Other | Unalloc. | Total | |||||||||||||||||||
Net sales |
$ | 1,796,286 | $ | 1,613,353 | $ | 884,750 | $ | 293,043 | $ | | $ | 4,587,432 | ||||||||||||
Cost of goods sold |
1,015,528 | 1,187,819 | 430,836 | 99,259 | | 2,733,442 | ||||||||||||||||||
Gross profit |
780,758 | 425,534 | 453,914 | 193,784 | | 1,853,990 | ||||||||||||||||||
Selling general and
adminstrative* |
307,975 | 145,389 | 302,698 | 181,998 | 329,635 | 1,267,695 | ||||||||||||||||||
Research and
development* |
| | | | 137,488 | 137,488 | ||||||||||||||||||
Income from
operations |
$ | 472,783 | $ | 280,145 | $ | 151,216 | $ | 11,786 | $ | (467,123 | ) | $ | 448,807 | |||||||||||
For the six months ended June 30, 2011 (previous segment method): |
IKONICS | ||||||||||||||||||||
Domestic | Export | Imaging | Unalloc. | Total | ||||||||||||||||
Net sales |
$ | 3,127,335 | $ | 2,809,566 | $ | 2,303,630 | $ | | $ | 8,240,531 | ||||||||||
Cost of goods sold |
1,761,536 | 2,069,545 | 1,088,617 | | 4,919,698 | |||||||||||||||
Gross profit |
1,365,799 | 740,021 | 1,215,013 | | 3,320,833 | |||||||||||||||
Selling, general and
administrative* |
584,480 | 277,863 | 980,426 | 768,567 | 2,611,336 | |||||||||||||||
Research and
development* |
| | | 237,399 | 237,399 | |||||||||||||||
Income from operations |
$ | 781,319 | $ | 462,158 | $ | 234,587 | $ | (1,005,966 | ) | $ | 472,098 | |||||||||
For the six months ended June 30, 2010 (previous segment method): |
IKONICS | ||||||||||||||||||||
Domestic | Export | Imaging | Unalloc. | Total | ||||||||||||||||
Net sales |
$ | 3,291,563 | $ | 2,629,779 | $ | 2,011,290 | $ | | $ | 7,932,632 | ||||||||||
Cost of goods sold |
1,701,356 | 1,805,715 | 1,112,007 | | 4,619,078 | |||||||||||||||
Gross profit |
1,590,207 | 824,064 | 899,283 | | 3,313,554 | |||||||||||||||
Selling, general and
administrative* |
486,607 | 325,654 | 568,067 | 942,536 | 2,322,864 | |||||||||||||||
Research and
development* |
| | | 365,202 | 365,202 | |||||||||||||||
Income from operations |
$ | 1,103,600 | $ | 498,410 | $ | 331,216 | $ | (1,307,738 | ) | $ | 625,488 | |||||||||
For the six months ended June 30, 2011 (new segment method): |
IKONICS | ||||||||||||||||||||||||
Domestic | Export | Imaging | Other | Unalloc. | Total | |||||||||||||||||||
Net sales |
$ | 3,127,335 | $ | 2,809,566 | $ | 1,775,669 | $ | 527,961 | $ | | $ | 8,240,531 | ||||||||||||
Cost of goods sold |
1,761,536 | 2,069,545 | 887,103 | 201,514 | | 4,919,698 | ||||||||||||||||||
Gross profit |
1,365,799 | 740,021 | 888,566 | 326,447 | | 3,320,833 | ||||||||||||||||||
Selling general and
adminstrative* |
584,480 | 277,863 | 599,938 | 380,488 | 768,567 | 2,611,336 | ||||||||||||||||||
Research and
development* |
| | | | 237,399 | 237,399 | ||||||||||||||||||
Income from
operations |
$ | 781,319 | $ | 462,158 | $ | 288,628 | $ | (54,041 | ) | $ | (1,005,966 | ) | $ | 472,098 | ||||||||||
10
Table of Contents
IKONICS CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
(Unaudited)
* | The Company does not allocate all general and administrative expenses or any research and development expenses to its operating segments for internal reporting. |
Accounts receivable related to the Other segment are included in IKONICS Imaging. Accounts receivable by segment as of June 30, 2011 and December 31, 2010 were as follows: |
June 30, 2011 | Dec 31, 2010 | |||||||
Domestic |
$ | 988,527 | $ | 874,535 | ||||
Export |
855,087 | 725,007 | ||||||
IKONICS Imaging |
404,865 | 325,334 | ||||||
Unallocated, net of allowances |
(21,770 | ) | (41,448 | ) | ||||
Total |
$ | 2,226,709 | $ | 1,883,428 | ||||
7. | Income Taxes |
The Company reports a liability for unrecognized tax benefits taken or expected to be taken when they are uncertain. During the first six months of 2010, the statute of limitations for the relevant taxing authority to examine and challenge the tax position for an open year expired, resulting in decreases in income tax expense of $27,000 for the first six months of 2010. As of June 30, 2011 and 2010, there was no liability for unrecognized tax benefits. |
The Company is subject to taxation in the United States and various states. The material jurisdictions that are subject to examination by tax authorities primarily include Minnesota and the United States, for tax years 2007, 2008, 2009, and 2010. |
11
Table of Contents
IKONICS CORPORATION
The information presented below in Managements Discussion and Analysis of Financial Condition
and Results of Operations contains forward-looking statements within the meaning of the safe harbor
provisions of Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are
subject to risks and uncertainties, including those discussed under Factors that May Affect Future
Results below, that could cause actual results to differ materially from those projected. Because
actual results may differ, readers are cautioned not to place undue reliance on these
forward-looking statements. Certain forward-looking statements are indicated by italics or by
words such as anticipate, believe, continue, could, estimate, expect, intend, may,
plan, potential, predict, project, should, will, would, or the negative of these
terms or other comparable terminology.
ITEM 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
The following managements discussion and analysis focuses on those factors that had a
material effect on the Companys financial results of operations during the second quarter of 2011,
the first six months of 2011 and for the same periods of 2010. It should be read in connection
with the Companys condensed unaudited financial statements and notes thereto included in this Form
10-Q. The discussion and analysis below with respect to IKONICS Imaging sales excludes
Micromaching and DTX sales for all applicable periods during 2010. See Note 6 to the Companys
condensed unaudited financial statements included in this Form 10-Q for more information regarding
the change to the Companys reported segments beginning in 2011.
Factors that May Affect Future Results
| The Companys expectation that its effective tax rate will return to 35% to 36% of pretax income for the remainder of 2011 compared to the tax rate of 27.9% in the first six months of 2011The effective tax rate for the final six months of 2011 may be affected by changes in federal and state tax law, unanticipated changes in the Companys financial position or the Companys operating activities and/or management decisions could increase or decrease its effective tax rate. | ||
| The Companys belief that the quality of its trade receivables is high and that strong internal controls are in place to maintain proper collectionsThis belief may be impacted by domestic economic conditions, by economic, political, regulatory or social conditions in foreign markets, or by the failure of the Company to properly implement or maintain internal controls. | ||
| The Companys expectation that it will obtain a new line of credit similar to its current line of credit when the current line of credit expires on October 30, 2011This expectation may be impacted by factors such as changes in credit markets, the interest rate environment, general economic conditions, the Companys financial results and condition, and the Companys anticipated need for capital to fund business operations and capital expenditures. | ||
| The belief that the Companys current financial resources, its line of credit, cash generated from operations and the Companys capacity for debt and/or equity financing will be sufficient to fund current and anticipated business operations and capital expenditures. The belief that the Companys low debt levels and available line of credit make it unlikely that a decrease in product demand would impair the Companys ability to fund operationsChanges in anticipated operating results, credit availability, equity market conditions or the Companys debt levels may further enhance or inhibit the Companys ability to maintain or raise appropriate levels of cash. | ||
| The Companys expectations as to the level and use of planned capital expenditures and that capital expenditures will be funded with cash on hand and cash generated from operating activitiesThis expectation may be affected by changes in the Companys anticipated capital expenditure requirements resulting from unforeseen required maintenance, repairs, or capital asset additions. The funding of planned or unforeseen expenditures may also be affected by changes in anticipated |
12
Table of Contents
operating results resulting from decreased sales, lack of acceptance of new products or increased operating expenses or by other unexpected events affecting the Companys financial position. | |||
| The Companys belief that its vulnerability to foreign currency fluctuations and general economic conditions in foreign countries is not significantThis belief may be impacted by economic, political and social conditions in foreign markets, changes in regulatory and competitive conditions, a change in the amount or geographic focus of the Companys international sales, or changes in purchase or sales terms. | ||
| The Companys expectation that research and development spending will grow and return to historic levelsThese plans and expectations may be impacted by the Companys ability to identify, hire and retain qualified personnel, unexpected changes to resource requirements for other areas of the Companys business, the Companys ability to identify new technologies for product development and the overall performance of the Company. | ||
| The Companys beliefs as to the future performance of its new technologies or particular segmentsActual performance may be impacted by general market conditions or conditions in particular industries in which the Companys products are used (including the aerospace and automotive industries), changes to the competitive landscape in the industries in which the Company competes (including pricing pressures from or new product offerings by existing or future competitors), lack of acceptance of new products or technologies, the availability of DTX printers that use the Companys products or increases to raw materials costs used to produce the Companys products. | ||
| The Companys efforts to grow its international businessThese efforts may be impacted by economic, political and social conditions in current and anticipated foreign markets, regulatory conditions in such markets, unanticipated changes in expenses or sales, changes in competitive conditions or other barriers to entry or expansion. | ||
| The Companys belief as to future activities that may be undertaken to expand the Companys businessActual activities undertaken may be impacted by general market conditions, competitive conditions in the industries in which the Company sells products, unanticipated changes in the Companys financial position, lack of acceptance of new products or the inability to identify attractive acquisition targets or other business opportunities. |
Critical Accounting Estimates
The Company prepares its financial statements in conformity with accounting principles
generally accepted in the United States of America. Therefore, the Company is required to make
certain estimates, judgments and assumptions that the Company believes are reasonable based upon
the information available. These estimates and assumptions affect the reported amounts of assets
and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the periods presented. The accounting estimates, which IKONICS believes are the
most critical to aid in fully understanding and evaluating its reported financial results, include
the following:
Trade Receivable. The Company performs ongoing credit evaluations of its customers and
adjusts credit limits based upon payment history and the customers current credit worthiness, as
determined by review of the current credit information. The Company continuously monitors
collections and payments from its customers and maintains a provision for estimated credit losses
based upon historical experience and any specific customer collection issues that have been
identified. While such credit losses have historically been within expectations and the provisions
established, the Company cannot guarantee that it will continue to experience the same collection
history that has occurred in the past. The general payment terms are net 30-45 days for domestic
customers and net 30-90 days for foreign customers. A small percentage of the trade receivable
balance is denominated in a foreign currency with no concentration in any given country. At the
end of each reporting period, the Company analyzes
13
Table of Contents
the receivable balance for customers paying in a foreign currency. These balances are adjusted to each
quarter or year spot rate in accordance with guidance related to foreign currency matters.
Inventories. Inventories are valued at the lower of cost or market value using the last in,
first out (LIFO) method. The Company monitors its inventory for obsolescence and records
reductions in cost when required.
Income Taxes. At June 30, 2011, the Company had net current deferred tax assets of $157,000
and net noncurrent deferred tax liabilities of $171,000. The deferred tax assets and liabilities
result primarily from temporary differences in property and equipment, accrued expenses, and
inventory reserves. In connection with the recording of a $919,000 impairment charge in 2009
related to an investment in a non-marketable equity security, the Company has recorded a deferred
tax asset and corresponding full valuation allowance in the amount of $323,000 as of June 30, 2011
and December 31, 2010 as it is more likely that this asset will not be realized. The deferred tax
asset related to the capital loss can be carried forward five years and must be offset by a capital
gain. The Company has determined that is more likely than not that the remaining deferred tax
assets will be realized and that an additional valuation allowance for such assets is not currently
required. The Company accounts for its uncertain tax positions under the provision of FASB ASC
740, Income Taxes. At June 30, 2011 the Company had no reserves for uncertain tax positions.
Revenue Recognition. The Company recognizes revenue on sales of products when title passes
which can occur at the time of shipment or when the goods arrive at the customer location depending
on the agreement with the customer. The Company sells its products to both distributors and
end-users. Sales to distributors and end-users are recorded based upon the criteria governed by
the sales, delivery, and payment terms stated on the invoices from the Company to the purchaser.
In addition to transfer of title / risk of loss, all revenue is recorded in accordance with the
criteria outlined within the provisions regarding revenue recognition including:
(a) | persuasive evidence of an arrangement (principally in the form of customer sales orders and the Companys sales invoices) | ||
(b) | delivery and performance (evidenced by proof of delivery, e.g. the shipment of film and substrates with bill of lading used for proof of delivery for FOB shipping point terms, and the carrier booking confirmation report used for FOB destination terms). Once the finished product is shipped and physically delivered under the terms of the invoice and sales order, the Company has no additional performance or service obligations to complete | ||
(c) | a fixed and determinable sales price (the Companys pricing is established and is not based on variable terms, as evidenced in either the Companys invoices or the limited number of distribution agreements; the Company rarely grants extended payment terms and has no history of concessions) | ||
(d) | a reasonable likelihood of payment (the Companys terms are standard, and the Company does not have a substantial history of customer defaults or non-payment) |
Sales are reported on a net basis by deducting credits, estimated normal returns and discounts.
The Companys return policy does not vary by geography. The Company is not under a warranty
obligation and the customer has no rotation or price protection rights. Freight billed to
customers is included in sales. Shipping costs are included in cost of goods sold.
Results of Operations
Quarter Ended June 30, 2011 Compared to Quarter Ended June 30, 2010
Sales. The Company realized an 8.0% sales increase during the second quarter of 2011 with
sales of $4.6 million, compared to $4.2 million in sales during the same period in 2010. Export
sales for the second quarter of 2011 were up 9.5% versus the second quarter of 2010 due to strong
sales in Latin America and Asia. Second
14
Table of Contents
quarter results in 2011 also benefitted from increased Micromachining and DTX sales, which grew from
$146,000 in the second quarter of 2010 to $293,000 in the same period in 2011. IKONICS Imaging
sales increased 5.6% during the second quarter of 2011 compared to the second quarter of 2010 due
to increased film and equipment sales while Domestic shipments were flat for the quarter.
Gross Profit. Gross profit was $1.9 million, or 40.4% of sales, in the second quarter of 2011
compared to $1.8 million, or 43.1% of sales, for the same period in 2010. Domestic gross profit
percentage, which decreased from 49.6% during the second quarter of 2010 to 43.5% in the second
quarter of 2011, and Export gross profit percentage, which also decreased from 31.8% in the second
quarter of 2010 to 26.4% in the second quarter of 2011, were both negatively impacted by a decrease
in higher margin film sales. Raw material price increases have also unfavorably affected 2011
second quarter margins. Gross margins were favorably impacted by the increase in the higher margin
sales related to Micromachining and DTX.
Selling, General and Administrative Expenses. Selling, general and administrative expenses
were $1.3 million, or 27.6% of sales, in the second quarter of 2011, and $1.1 million, or 26.4% of
sales, for the same period in 2010. The increase in selling, general and administrative expenses
reflects higher personnel, promotion and consulting costs related to supporting the Companys
Micromachining and DTX initiatives. Part of the higher personnel expenses are related to resources
that were previously assigned to research and development, but have been reassigned to focus
exclusively on Micromachining and DTX.
Research and Development Expenses. Research and development expenses during the second
quarter of 2011 were $137,000, or 3.0% of sales, versus $204,000, or 4.8% of sales, for the same
period in 2010. The decrease is due to lower staffing levels due to the reassignment of certain
personnel to the Companys Micromachining and DTX initiatives. Additionally, legal and patent
related expenses were lower in the second quarter of 2011 along with research related production
trials.
Interest Income. The Company earned $4,800 of interest income in the second quarter of 2011
compared to $3,900 of interest income in the second quarter of 2010. The interest earned in second
quarter of 2011 and 2010 is related to interest received from the Companys short-term investments,
which consisted of fully insured certificates of deposit with maturities ranging from six to twelve
months.
Income Taxes. For the second quarter of 2011, the Company realized income tax expense of
$144,000, or an effective rate of 31.8%, versus $163,000, or an effective rate of 32.2% for the
second quarter of 2010. The income tax provision differs from the expected tax expense primarily
due to the benefits of the domestic manufacturing deduction, and federal and state credits for
research and development.
Six Months Ended June 30, 2011 Compared to the Six Months Ended June 30, 2010
Sales. The Companys sales increased 3.9% during the first six months of 2011 to $8.2 million
versus sales of $7.9 million during the first six months of 2010. Strong sales in Asia and Latin
America drove a 6.8% Export sales increase for the first six months of 2011 compared to the same
period in 2010. DTX and Micromachining sales also grew 88.6% from $280,000 in the first half of
2010 to $528,000 in the same period of 2011. IKONICS Imaging sales increased 2.6% during the first
six months of 2011 compared to the first six months of 2010 due to increased film and equipment
sales. Partially offsetting these sales increases was a 5.0% Domestic sales decrease. Domestic
sales in 2010 benefitted from a large private label film sale which did not occur in 2011.
Gross Profit. Gross profit for the first six months of 2011 was $3.3 million, or 40.3% of
sales, compared to $3.3 million, or 41.8% of sales, for the same period in 2010. Export and
Domestic gross profit percentage decreased by 5.0% and 4.6%, respectively, during the first half of
2011 compared to the same period in 2010. The decrease in higher margin film sales along with raw
material price increases have unfavorably affected the gross profit percentage for Export and
Domestic. Higher margin DTX and Mircomachining sales partially offset the Export and Domestic
gross margin decreases.
15
Table of Contents
Selling, General and Administrative Expenses. Selling, general and administrative expenses
were $2.6 million, or 31.7% of sales, in the first half of 2011 compared to $2.3 million, or 29.3%
of sales, for the same period in 2010. The increase in selling, general and administrative
expenses reflects higher personnel, promotion and consulting costs related to supporting the
Companys Micromachining and DTX initiatives. Part of the higher personnel expenses are related to
resources that were previously assigned to research and development, but have been reassigned to
focus exclusively on Micromachining and DTX.
Research and Development Expenses. Research and development expenses during the first
half of 2011 were $237,000, or 2.9% of sales, versus $365,000, or 4.6% of sales, for the same
period in 2010. The decrease is due to lower staffing levels due to the reassignment of certain
personnel to the Companys Micromachining and DTX initiatives. Additionally, legal and patent
related expenses were lower in 2011 along with research related production trials.
Interest Income. The Company earned $9,300 of interest income during the first half of 2011
compared to $7,400 of interest income for the same period in 2010. The interest earned in first
six months of 2011 and 2010 is related to interest received from the Companys short-term
investments, which consisted of fully insured certificates of deposit with maturities ranging from
six to twelve months.
Income Taxes. During the first six months of 2011, the Company realized an income tax expense
of $135,000, or an effective rate of 27.9%, compared to income tax expense of $141,000, or an
effective rate of 22.3%, for the same period in 2010. The income tax provision for 2011 and 2010
differs from the expected tax expense due to the benefits of the domestic manufacturing deduction,
and federal and state credits for research and development. Additionally, the effective tax rate
for the first six months of 2010 was impacted by derecognizing a liability for unrecognized tax
benefits relating to a tax year where the statute of limitations expired during the first six
months. A $27,000 liability was derecognized in the first half of 2010. During the first half of
2010, the Company also recorded an out-of-period tax benefit adjustment of $15,000 relating to
December 31, 2009 estimates for tax credits as well as the receipt of interest of approximately
$13,000 related to Minnesota state income tax returns. The Company expects that for the remainder
of 2011, the Company will record the provision for income taxes at an effective tax rate of 35% to
36%.
Liquidity and Capital Resources
The Company has financed its operations principally with funds generated from operations.
These funds have been sufficient to cover the Companys normal operating expenditures, annual
capital requirements, and research and development expenditures.
Cash on hand was $1,103,000 and $1,068,000 at June 30, 2011 and 2010, respectively. The
Company used $84,000 in cash from operating activities during the six months ended June 30, 2011,
compared to generating $662,000 of cash from operating activities during the same period in 2010.
Cash used in or provided by operating activities is primarily the result of net income adjusted for
non-cash depreciation, amortization, and certain changes in working capital components discussed in
the following paragraph.
During the first six months of 2011, trade receivables increased by $343,000. The increase in
receivables was driven by higher sales volumes especially in Export where customers typically have
longer payment terms. The Company believes that the quality of its receivables is high and that
strong internal controls are in place to maintain proper collections. Inventories increased by
$380,000 due to increased raw material purchases. The higher raw material purchases were due to
the timing of a large restocking order, an increase in order quantities to take advantage of volume
discounts and new raw materials necessary to support the manufacture and sale of the Companys new
products. Prepaid expenses and other assets increased $38,000 reflecting prepaid insurance
premiums. Accounts payable increased $21,000 due to of the timing of payments to and purchases
from vendors. Accrued expenses decreased $71,000, reflecting the timing of compensation payments
while the impact from income taxes payable increased cash by $4,000.
During the first half of 2011, investing activities used $170,000. The Companys purchases of
equipment for the quarter were $115,000, mainly for equipment purchases and hardware upgrades to
the Companys computer
16
Table of Contents
network. Also during the first quarter of 2011, the Company incurred
$42,000 in patent application costs that the Company records as an asset and amortizes upon
successful completion of the application process. The Company invested $1,828,000 in fully
insured certificates of deposits with nine certificates of deposit totaling $1,814,000 maturing
during the first six months of 2011.
During the first half of 2010, investing activities used $933,000. The Company invested
$1,207,000 in fully insured certificates of deposits with two $200,000 certificates of deposit
maturing during the first six months of 2010. Purchases of property and equipment were $122,000,
mainly for three vehicles and equipment purchases. The Company received $19,000 from vehicle
sales. Also during the first six months of 2010, the Company incurred $23,000 in patent
application costs that the Company records as an asset and amortizes upon successful completion of
the application process.
During the first six months of 2011, the Company received $66,000 from financing activities as
the Company received $68,000 from the issuance of 10,500 shares of common stock from the exercise
of stock options. The Company used $2,100 in financing activities during the first half of 2011 to
repurchase 270 shares of its own stock. During the first six months of 2010, the Company received
$34,000 from financing activities from the issuance of 7,750 shares of common stock upon the
exercise of stock options.
A bank line of credit exists providing for borrowings of up to $1,250,000. The line of credit
term runs from October 31, 2010 to October 30, 2011. The Company expects to obtain a similar line
of credit when the current line of credit expires. The line of credit is collateralized by trade
receivables and inventories and bears interest at 2.5 percentage points over the 30-day LIBOR rate.
The Company did not utilize this line of credit during the first six months of 2011 or 2010, and
there were no borrowings outstanding as of June 30, 2011 and 2010. There are no financial
covenants related to the line of credit.
The Company believes that current financial resources, its line of credit, cash generated from
operations and the Companys capacity for debt and/or equity financing will be sufficient to fund
current and anticipated business operations. The Company also believes that its low debt levels
and available line of credit make it unlikely that a decrease in demand for the Companys products
would impair the Companys ability to fund operations.
Capital Expenditures
Through the first six months of 2011, the Company had $115,000 in capital expenditures.
Capital expenditures during the first six months were mainly for equipment and computer network
upgrades. The Company expects capital expenditures in 2011 of approximately $650,000. Plans for
capital expenditures include two mandatory elevator upgrades, manufacturing equipment upgrades to
improve quality and increase production and a vehicle. These commitments are expected to be funded
with cash on hand and cash generated from operating activities.
International Activity
The Company markets its products to numerous countries in North America, Europe, Latin
America, Asia and other parts of the world. Foreign sales were approximately 34% of total sales
during the first six months of 2011 compared to 33% of sales during the same period in 2010.
Higher volumes in Asia and Latin American positively impacted 2011 first half sales volumes.
Fluctuations of certain foreign currencies have not significantly impacted the Companys operations
because the Companys foreign sales are not concentrated in any one region of the world and the
majority of international sales are conducted in U.S. dollars. The Company believes its
vulnerability to uncertainties due to foreign currency fluctuations and general economic conditions
in foreign countries is not significant.
The Companys foreign transactions are primarily negotiated, invoiced and paid in U.S.
dollars, while a portion is transacted in Euros. IKONICS has not implemented an economic hedging
strategy to reduce the risk of foreign currency translation exposures, which management does not
believe to be significant based on the scope and geographic diversity of the Companys foreign operations as of June 30, 2011. Furthermore, the
impact of foreign exchange on the Companys balance sheet and operating results was not material in
either 2011 or 2010.
17
Table of Contents
Future Outlook
IKONICS has spent on average over 4% of its sales dollars for the past few years in research
and development; in the first half of 2011 this dropped to 3%. The 2011 first half reduction is
due to the Company moving to commercialize its new technologies (Micro Machining and Industrial
Inkjet Solutions). Two chemists who were intimately involved in the development of these
technologies have been made their Product Managers. This reassignment puts the Companys technical
people, with their broad product knowledge, directly in contact with industrial customers, who
demand technical sales and support. In connection with the reassignment of these two chemists, the
Company began including their compensation in selling, general and administrative expenses. As new
research projects are identified, the Company anticipates that its Research and Development staff
will grow to meet these needs and spending will return to historic levels.
The new technologies of Micromachining and Industrial Inkjet (DTX) grew rapidly during the
first half of 2011 and represented a small but increasing portion of the Companys sales. For the
first half of 2011 their combined sales were 88% percent above the first six months of 2010, and
the Company anticipates further strong growth. Micromachinings aviation sound deadening
technology has shown growth with several new customers interested in adopting the Companys
technology, and the Company believes there are new opportunities for the machining of composite
materials for the aerospace industry. The Companys machining of electronic wafers is also showing
increased profitability. The Company believes Micromachining offers a unique value proposition,
which the industry is just beginning to recognize.
DTX is a proprietary system for putting textures into steel molds for the plastic
injection mold making; the primary end customer is automotive. The Company sells inkjet fluid and
custom made substrates for use by printers supplied by the Company and its strategic partners,
Colour Scanner Technology GMBH and the Trans Tech division of Illinois Tool Works Inc. IKONICS was
awarded a European patent on its DTX technology in 2010 and has a patent pending in North America
and Japan. The first DTX printer was sold in 2010 to a domestic customer, and it is generating
consumable sales. Several potential customers, world-wide, have evidenced interest in this
technology, and the Company anticipates sales once its strategic partners have printers available.
The Companys strategic partners have been reluctant to manufacture these specialized printers
until market demand became evident; the Company believes that this is now evident and printers are
in production.
In 2010, the Company developed and applied for a patent on its I-HE photo resist film for
the etching of electronic wafers and developed I-XE low silicone photo resist film for the
aerospace industry. Both films have been well received and have begun to generate profitable sales
which the Company believes will continue in the second half of 2011.
Domestically, the Company has combined its Chromaline Screen Print Product and its
IKONICS Imaging units under one leadership. These have been profitable mature markets and require
aggressive strategies to grow market share. Although there will be challenges, the Company believes
these businesses will continue to grow and prosper.
In addition to its traditional emphasis on domestic markets, the Company will continue
efforts to grow its business internationally by attempting to develop new markets and expanding
market share where it has already established a presence.
The Company believes that its traditional businesses will show steady growth worldwide
and that its new businesses will display accelerated growth.
Other future activities undertaken to expand the Companys business may include
acquisitions, building improvements, equipment additions, new product development and marketing
opportunities.
18
Table of Contents
Recent Accounting Pronouncements
The Company does not expect that the adoption of recent accounting pronouncements will have a
material impact on its financial statements.
Off Balance Sheet Arrangements
The Company has no off-balance sheet arrangements.
19
Table of Contents
ITEM 3. | Quantitative and Qualitative Disclosures about Market Risk |
Not applicable
ITEM 4. | Controls and Procedures |
As of the end of the period covered by this report, the Company conducted an evaluation, under
the supervision and with the participation of the principal executive officer and principal
financial officer, of the Companys disclosure control and procedures (as defined in Rules
13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the Exchange Act)). Based on
this evaluation, the principal executive officer and principal financial officer concluded that the
Companys disclosure controls and procedures are effective to ensure that information required to
be disclosed by the Company in reports that it files or submits under the Exchange Act is (i)
recorded, processed, summarized and reported within the time periods specified in SEC rules and
forms and (ii) accumulated and communicated to the Companys management, including its principal
executive officer and principal financial officer, as appropriate to allow timely decisions
regarding required disclosure.
There was no change in the Companys internal control over financial reporting identified in
connection with the evaluation required by Rule 13a-15(d) and Rule 15d-15(d) of the Exchange Act
that occurred during the period covered by this report that has materially affected, or is
reasonably likely to materially affect, the Companys internal control over financial reporting.
20
Table of Contents
PART II. OTHER INFORMATION
ITEM 1. | Legal Proceedings |
None
ITEM 1A. | Risk Factors |
Not applicable
ITEM 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
The Company repurchased shares as indicated in the table below during the second
quarter of 2011(1):
(c) Total Number of | ||||||||||||||||
Shares Purchased as | (d) Maximum Number of | |||||||||||||||
(a) Total Number | Part of Publicly | Shares that May | ||||||||||||||
of | (b) Average Price | Announced Plans | Yet Be Purchased Under | |||||||||||||
Shares Purchased | Paid per Share | or Programs | The Plans or Programs | |||||||||||||
April 1, 2011 through April 30, 2011 |
| n/a | | 33,031 | ||||||||||||
May 1, 2011 through May 31, 2011 |
270 | $ | 7.70 | 270 | 32,761 | |||||||||||
June 1, 2011 through June 30, 2011 |
| n/a | | 32,761 | ||||||||||||
Total |
270 | $ | 7.70 | 270 | 32,761 |
(1) | In prior years, the Companys board of directors had authorized the repurchase of 150,000 shares of common stock. In August 2008, the Companys Board of Directors approved the repurchase of an additional 100,000 shares of common stock bringing the total shares eligible for repurchase to 250,000. A total of 206,640 shares have been repurchased under this program including 270 shares repurchased during the second quarter of 2011. The plan allows for an additional 32,761 shares to be repurchased. |
ITEM 3. | Defaults upon Senior Securities |
Not applicable
ITEM 4. | [Removed and Reserved] |
ITEM 5. | Other Information |
None
ITEM 6. | Exhibits |
The following exhibits are filed as part of this Quarterly Report on Form 10-Q for the
quarterly period ended June 30, 2011:
Exhibit | Description | |
3.1 | Restated Articles of Incorporation of Company, as amended.1 |
|
3.2 | By-Laws of the Company, as amended.2 |
|
31.1 | Rule 13a-14(a)/15d-14(a) Certifications of CEO |
|
31.2 | Rule 13a-14(a)/15d-14(a) Certifications of CFO |
|
32 | Section 1350 Certifications |
|
101 | Interactive Data Files Pursuant to Rule 405 of Regulation S-T |
1 | Incorporated by reference to the like numbered Exhibit to the Companys Registration Statement on Form 10-SB (File No. 000-25727). | |
2 | Incorporated by reference to the like numbered Exhibit to the Companys Current Report on Form 8-K filed with the Commission on February 22, 2007 (File No. 000-25727). |
Copies of Exhibits will be furnished upon request and payment of the Companys reasonable
expenses in furnishing the Exhibits.
21
Table of Contents
IKONICS CORPORATION
SIGNATURES
In accordance with the requirements of the Securities Exchange Act of 1934, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
IKONICS CORPORATION | ||||||
DATE: August 12, 2011
|
By: | /s/ Jon Gerlach
|
||||
Chief Financial Officer, and Vice President of Finance |
22
Table of Contents
INDEX TO EXHIBITS
Exhibit | Description | Page | ||
3.1
|
Restated Articles of Incorporation of Company, as amended | Incorporated by reference | ||
3.2
|
By-Laws of the Company, as amended | Incorporated by reference | ||
31.1
|
Rule 13a-14(a)/15d-14(a) Certifications of CEO | Filed Electronically | ||
31.2
|
Rule 13a-14(a)/15d-14(a) Certifications of CFO | Filed Electronically | ||
32
|
Section 1350 Certifications | Filed Electronically | ||
101
|
Interactive Data Files Pursuant to Rule 405 of Regulation S-T | Filed Electronically |